These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 20206839)

  • 1. Clinical characteristics of Taiwanese children with congenital adrenal hyperplasia caused by 21-hydroxylase deficiency in the pre-screening era.
    Lee CT; Tung YC; Hsiao PH; Lee JS; Tsai WY
    J Formos Med Assoc; 2010 Feb; 109(2):148-55. PubMed ID: 20206839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics of Taiwanese children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency detected by neonatal screening.
    Liu SY; Lee CT; Tung YC; Chien YH; Hwu WL; Tsai WY
    J Formos Med Assoc; 2018 Feb; 117(2):126-131. PubMed ID: 28392195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Coeli-Lacchini FB; Turatti W; Elias PC; Elias LL; Martinelli CE; Moreira AC; Antonini SR; de Castro M
    Gene; 2013 Sep; 526(2):239-45. PubMed ID: 23570880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular testing in congenital adrenal hyperplasia due to 21α-hydroxylase deficiency in the era of newborn screening.
    Sarafoglou K; Lorentz CP; Otten N; Oetting WS; Grebe SK
    Clin Genet; 2012 Jul; 82(1):64-70. PubMed ID: 21534945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal screening: identification of children with 11β-hydroxylase deficiency by second-tier testing.
    Janzen N; Riepe FG; Peter M; Sander S; Steuerwald U; Korsch E; Krull F; Müller HL; Heger S; Brack C; Sander J
    Horm Res Paediatr; 2012; 77(3):195-9. PubMed ID: 22508345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical features and genetic characteristics of 33 patients with simple virilizing form of 21-hydroxylase deficiency].
    Zeng LT; Han B; Liu BL; Chen X; Zhu H; Chen Y; Chen M; Liu JH; Liu Y; Qiao J
    Zhonghua Nei Ke Za Zhi; 2019 Jun; 58(6):428-434. PubMed ID: 31159521
    [No Abstract]   [Full Text] [Related]  

  • 7. Phenotype and genotype correlation of the microconversion from the CYP21A1P to the CYP21A2 gene in congenital adrenal hyperplasia.
    Torres N; Mello MP; Germano CM; Elias LL; Moreira AC; Castro M
    Braz J Med Biol Res; 2003 Oct; 36(10):1311-8. PubMed ID: 14502362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in the diagnosis and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Forest MG
    Hum Reprod Update; 2004; 10(6):469-85. PubMed ID: 15514016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular genetic analysis in 93 patients and 193 family members with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Croatia.
    Dumic KK; Grubic Z; Yuen T; Wilson RC; Kusec V; Barisic I; Stingl K; Sansovic I; Skrabic V; Dumic M; New MI
    J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt A):51-56. PubMed ID: 27041116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of phenotypes and genotypes in 84 patients with 21-Hydroxylase deficiency in southern China.
    Hou L; Liang L; Lin S; Ou H; Liu Z; Huang S; Zhang L; Meng Z
    Steroids; 2019 Nov; 151():108474. PubMed ID: 31446012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CYP21A2 gene mutations in congenital adrenal hyperplasia: genotype-phenotype correlation in Turkish children.
    Baş F; Kayserili H; Darendeliler F; Uyguner O; Günöz H; Yüksel Apak M; Atalar F; Bundak R; Wilson RC; New MI; Wollnik B; Saka N
    J Clin Res Pediatr Endocrinol; 2009; 1(3):116-28. PubMed ID: 21274396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Splicing mutation in CYP21 associated with delayed presentation of salt-wasting congenital adrenal hyperplasia.
    Kohn B; Day D; Alemzadeh R; Enerio D; Patel SV; Pelczar JV; Speiser PW
    Am J Med Genet; 1995 Jul; 57(3):450-4. PubMed ID: 7677150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neonatal screening for congenital adrenal hyperplasia: transitory elevation of 17-hydroxyprogesterone.
    Huidobro Fernández B; Echeverria Fernández M; Dulin Iñiguez E; Ezquieta Zubicaray B; Roldán Martín MB; Rodríguez Arnao MD; Rodríguez Sánchez A
    J Pediatr Endocrinol Metab; 2011; 24(3-4):155-62. PubMed ID: 21648283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormonal disturbances due to severe and mild forms of congenital adrenal hyperplasia are already detectable in neonatal life.
    Faurschou S; Mouritsen A; Johannsen TH; Hougaard DM; Cohen A; Duno M; Juul A; Main KM
    Acta Paediatr; 2015 Feb; 104(2):e57-62. PubMed ID: 25346389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotype and hormonal phenotype in nonclassical 21-hydroxylase deficiency.
    Speiser PW; New MI
    J Clin Endocrinol Metab; 1987 Jan; 64(1):86-91. PubMed ID: 3023431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The distribution of intrafamilial CYP21A2 mutant alleles and investigation of clinical features in Turkish children and their siblings in Southeastern Anatolia.
    Karaoglan M
    J Pediatr Endocrinol Metab; 2019 Dec; 32(12):1311-1320. PubMed ID: 31693496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient hyper-17-hydroxyprogesteronemia: a clinical subgroup of patients diagnosed at neonatal screening for congenital adrenal hyperplasia.
    Cavarzere P; Samara-Boustani D; Flechtner I; Dechaux M; Elie C; Tardy V; Morel Y; Polak M
    Eur J Endocrinol; 2009 Aug; 161(2):285-92. PubMed ID: 19451212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular CYP21A2 diagnosis in 480 Brazilian patients with congenital adrenal hyperplasia before newborn screening introduction.
    de Carvalho DF; Miranda MC; Gomes LG; Madureira G; Marcondes JA; Billerbeck AE; Rodrigues AS; Presti PF; Kuperman H; Damiani D; Mendonca BB; Bachega TA
    Eur J Endocrinol; 2016 Aug; 175(2):107-16. PubMed ID: 27185867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and molecular profile of newborns with confirmed or suspicious congenital adrenal hyperplasia detected after a public screening program implementation.
    Kopacek C; Prado MJ; da Silva CMD; de Castro SM; Beltrão LA; Vargas PR; Grandi T; Rossetti MLR; Spritzer PM
    J Pediatr (Rio J); 2019; 95(3):282-290. PubMed ID: 29715434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital adrenal hyperplasia: update on prenatal diagnosis and treatment.
    Carlson AD; Obeid JS; Kanellopoulou N; Wilson RC; New MI
    J Steroid Biochem Mol Biol; 1999; 69(1-6):19-29. PubMed ID: 10418977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.